Introduction
Scars result from the cutaneous wound healing process, leading to fibrosis and altered skin morphology. All wounds heal with some scar formation, and various scars can develop following surgery, trauma, and cutaneous inflammatory processes.[1] Scars can have significant cosmetic, physical, and psychological impacts on patients, prompting many to seek treatment. Various treatment modalities have been utilized, with increasing evidence demonstrating lasers' efficacy in improving different types of scars, including keloids, hypertrophic scars, atrophic scars, and acne scars.[2]Modern advancements in laser technology have enhanced the ability of laser devices to improve the appearance, symptoms, texture, and pliability of all scar types.
Anatomy and Physiology
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
Scar formation occurs due to cutaneous dermal injury. It is influenced by various etiologic factors: genetic predisposition, depth, type, and location of the skin injury, the degree of tension, local infection or inflammation, and hormonal influences.[3][4] Hypertrophic scars and keloids characteristically demonstrate abnormal fibroblast proliferation and excessive collagen production in response to a range of skin injuries, often arising with a familial tendency.[5] Hypertrophic scars and keloids occur most commonly in those ages 10 to 30, with males and females equally affected.[4] Keloids occur with a higher prevalence in African-American, Hispanic, and Asian populations, with an incidence of 4 to 16%.[6] Hypertrophic scars result from excessive collagen synthesis with insufficient collagen lysis during the remodeling phase, forming thick, hyalinized collagen bundles of fibroblasts and fibrocytes.[5] In keloids, increased production of transforming growth factor-beta results in a prolonged proliferative phase of wound healing and significantly increased collagen synthesis by fibroblasts.[7]
In contrast, atrophic scars are characterized by dermal depressions that develop due to collagen destruction induced by cutaneous inflammation.[8] This type of scar commonly occurs in inflammatory diseases, such as acne vulgaris, varicella, and lupus, but may also result from surgery or trauma. Atrophic scars occur most commonly in patients with acne vulgaris, which affects up to 80% of those ages 11 to 30.[2] Atrophic scars are 3 times as common as keloids or hypertrophic scars[9]. Atrophic scars result from diminished deposition of collagen factors due to an imbalance between the synthesis of scar matrix components and their degradation by proteases.[9]
Indications
Indications for laser scar revision include atrophic, hypertrophic, and keloid scars in patients who desire an improvement in scar appearance and texture. Hypertrophic scars are red or pink, firm, raised scars that remain within the border of the initial injury. They form within the first month after the initial injury and may regress.[2] Keloids are pink to purple, nodular, firmer scars extending beyond the original wound's margins. They may occur weeks to years after the initial injury and do not regress spontaneously.[2] Atrophic scars subclassify into ice pick, boxcar, and rolling scars. Ice pick scars are narrow, deep, sharply marginated tracts that taper to a point at the base and extend vertically to the deep dermis or subcutaneous tissue.[2] Boxcar scars are round to oval depressions wider than ice-pick scars with sharply demarcated vertical edges. Rolling scars are wider than icepick or boxcar scars and characteristically show an undulating appearance of the skin due to abnormal fibrous tethering of the dermis to the subcutis.[9]
Contraindications
Contraindications to laser therapy include the use of oral retinoids within the past year, pregnancy or breastfeeding, immunosuppression, connective tissue disorders, and the presence of any concomitant skin disease at the site of treatment. It is important to elicit information regarding herpes simplex virus history so prophylactic antiviral therapy can commence before the laser treatment.
Equipment
Equipment required for the laser revision of scars include:
- Laser machine
- Digital camera
- Tray with a local anesthetic, post-laser emollient cream, anti-irritation gel, measurement tape
Personnel
Personnel required for the laser revision of scars include:
- Dermatologist
- Aesthetic medicine specialist
- Plastic surgeon
- Dermatology nurse
- Laser technician/ technologist
- Aesthetic technologist
Preparation
Scars should be thoroughly evaluated using a combination of clinical assessment and patient history to guide the appropriate treatment plan. They should be categorized as hypertrophic, keloidal, atrophic, or conventional. A history of the scar should be obtained to elucidate its age, previous scar treatments, and the preceding trauma, surgery, or inflammatory process. The patient's Fitzpatrick skin phototype should be a consideration. Pictures and measurements taken before each laser treatment can assist in monitoring progress and response to treatment. Scars should be clinically assessed at each visit, documenting pigmentation, pliability, and scar height. The scar should be treated with a topical anesthetic (eg, a cream) between 30 and 60 minutes before beginning treatment. The treatment area should be cleaned with an antiseptic solution before laser treatment.
Technique or Treatment
Laser scar revision utilizes photothermal energy to target intra- and extra-cellular structures within scar tissue to stimulate the eventual remodeling of dermal collagen and elastin. Various types of lasers have been used to treat scars since the 1980s, beginning with continuous-wave argon, CO2, and Nd:YAG 1064 lasers, followed by the application of PDL and Er:YAG lasers for scar revision.[10] Most recently, fractional photothermolysis with ablative and non-ablative fractionated lasers is an effective treatment for scars.[2]
For hypertrophic scars and keloids, the pulsed dye laser is the most common non-ablative laser (PDL: 585 to 595 nm).[2] PDL effectively improves hypertrophic scars and keloids' vascularity, pliability, color, and height.[11] Previous studies have reported a 57% to 83% improvement in hypertrophic scars' clinical appearance and texture after 1 to 2 PDL treatments.[12]. The most commonly used non-ablative lasers for atrophic facial scars are Nd: YAG and 1450-nm diode laser. One study reported an improvement of 40 to 45% with 1320-nm Nd: YAG or 1450-nm diode laser treatment after an average of 3 consecutive monthly treatment sessions, as assessed by patient satisfaction surveys, histologic evaluations, and skin texture measurements.[2] Non-ablative lasers have minimal downtime and produce gradual results, with the most significant improvement noted between 3 and 6 months following the final laser treatment.[2]
Non-ablative fractional lasers have significantly improved the pigmentation and thickness of surgical, atrophic, hypertrophic, and hypopigmented scars.[13] A study by Tierney et al comparing 1550-nm non-ablative fractional lasers to 595-nm PDL for the treatment of surgical scars showed that non-ablative fractional lasers outperformed PDL, and 83% of patients preferred the half of the scar treated with a non-ablative fractional laser.[13][14] Niwa et al examined non-ablative fractional lasers in treating hypertrophic scars and found 26% to 75% clinical improvement after 2 to 3 treatment sessions at 4-week intervals.[10]
Ablative laser resurfacing, with CO2 or Er: YAG lasers, is effective for traumatic and surgical scars, especially when resurfaced within 6 to 10 weeks after trauma or surgery or even immediately after surgery.[15] CO2 and Er:YAG lasers are also effective for atrophic scars due to their ability to smooth scar texture and stimulate collagen production within facial atrophic scars,[16] although patients must consider the potential for significant downtime as re-epithelialization typically takes 4 to 7 days with Er: YAG and 7 to 10 days with the CO2 laser. While requiring more downtime, ablative lasers usually produce more clinical improvement.
Previous head-to-head studies have suggested that CO2 laser produces superior results for acne scars, while Er:YAG is better tolerated with less downtime.[17] Raised and shallow boxcar scars improve the most with laser resurfacing, while icepick scars are more challenging to treat and may necessitate secondary resurfacing.[15] Non-ablative lasers are also useful for acne scars.
More recently, fractional ablative laser resurfacing has emerged as a popular treatment modality for atrophic and surgical scars. In fractional ablative resurfacing, columns of thermal damage, called microscopic thermal treatment zones, are separated by surrounding untreated skin. This results in rapid re-epithelialization and reduced downtime as only a fraction of the skin is altered.[18] The microthermal treatment zones also allow fractional lasers to penetrate the skin more deeply than fully ablative lasers.[19] A double-blinded split-scar study by Tidwell et al reported a significantly superior outcome with fractionated Er: YAG compared to fully ablative Er: YAG for surgical scar revision, with 94% of patients preferring the side of the scar treated with fractional ablative resurfacing.[19] Another study showed fractional CO2 laser to be effective in treating atrophic traumatic scars in 70% of patients treated with 6 monthly sessions of fractional CO2 laser treatment.[18]
Complications
Adverse effects of non-ablative laser options are generally mild and include transient erythema, which resolves within 24 hours. Blistering, crusting, scarring, and post-inflammatory hyperpigmentation are rare and occur most commonly in darker skin types.[2] The most frequently encountered side effect of PDL treatment is post-treatment purpura, lasting for up to 1 week.[20]
Non-ablative fractional resurfacing laser adverse effects include mild to moderate pain during treatment and erythema and edema post-treatment lasting up to 2 to 4 days.[15]
Side effects of ablative laser resurfacing include temporary burning discomfort, oozing, crusting, ulceration, erythema, edema, acneiform eruptions, eczematous dermatitis, and infections.[15] Long-term adverse effects include dyspigmentation and scarring.[18] Erythema and edema typically worsen within the first 24 to 48 hours after treatment, with erythema occasionally lasting up to 4 months post-treatment. One study reported an average duration of post-treatment erythema for 1 month.[21] Transient postinflammatory hyperpigmentation occurs 2 to 4 weeks after treatment and is more common in darker skin phototypes. In a study of Fitzpatrick skin types III to V, 45.5% developed transient hyperpigmentation that resolved within 3 months in 90% of affected patients.[21]
Fractional ablative laser resurfacing adverse effects are generally transient and less severe than fully ablative resurfacing.[20][18] Erythema, crusting, burning sensation, edema, and bruising were reported after fractional CO2 laser treatment.[18] Persistent erythema and postinflammatory pigmentary changes are less common complications when compared to fully ablative skin resurfacing.[18]
Clinical Significance
Laser therapy for the treatment is an effective and safe treatment modality for multiple types of scars. Several studies have demonstrated high patient satisfaction rates with the cosmetic outcome of various laser treatments. The emergence of fractional ablative laser devices has led to superior outcomes with decreased downtime compared to traditional fully ablative lasers, thereby increasing the appeal of laser treatment for patients. In addition to making existing scars less noticeable, laser therapy can be used prophylactically to minimize post-operative scarring.[11] For symptomatic scars, lasers can reduce pruritus and pain. Lastly, laser treatment can increase the range of motion of debilitating scars that restrict movement.
Enhancing Healthcare Team Outcomes
Scar revision using laser technology is an interprofessional process that involves the interplay of the primary caregiver, nurse practitioner, surgeon, and a dermatologist with a special interest in aesthetics to achieve the best possible outcome for the patient. Primary healthcare professionals should refer patients with scars to a board-certified dermatologist or plastic surgeon with the necessary medical expertise and specialized knowledge in treating scars with lasers. A medical consultation to review the patient's overall health, comorbidities, skin type, and scar characteristics is essential to treat a scar effectively. The outcomes of patients with scars are variable. In some cases, skin aesthetics can improve cosmesis. Lasers can cause several complications that can worsen the appearance of scars. Hence, laser therapy for scars requires professionals with experience with this device. The nurse has a crucial role in addressing the patient's fears and concerns before the day of surgery and assisting the clinician in educating the patient. A follow-up of laser therapy in scar treatment requires an interprofessional approach with a liaison between the dermatologist and nursing staff, who have specialized training in dermatology, as the nurse may well be the initial point of contact and education for follow-up care. This team approach can ensure the best possible patient outcomes.
Nursing, Allied Health, and Interprofessional Team Interventions
Ensure that the patient gives informed consent and is aware of the potential complications of the laser. In addition, the nurse should note the surgery site and record the findings in the chart.
Nursing, Allied Health, and Interprofessional Team Monitoring
Considerations for interprofessional team monitoring include the following:
- Vital signs
- Wound care
- Monitor for signs of infection
- Monitor for signs of skin irritation
References
English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 1999 Aug:25(8):631-8 [PubMed PMID: 10491047]
Khatri KA, Mahoney DL, McCartney MJ. Laser scar revision: A review. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology. 2011 Apr:13(2):54-62. doi: 10.3109/14764172.2011.564625. Epub [PubMed PMID: 21401378]
Alster TS. Laser treatment of hypertrophic scars, keloids, and striae. Dermatologic clinics. 1997 Jul:15(3):419-29 [PubMed PMID: 9189679]
Niessen FB,Spauwen PH,Schalkwijk J,Kon M, On the nature of hypertrophic scars and keloids: a review. Plastic and reconstructive surgery. 1999 Oct; [PubMed PMID: 10513931]
Level 3 (low-level) evidenceWolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2009 Feb:35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x. Epub [PubMed PMID: 19215252]
Level 3 (low-level) evidenceRobles DT, Berg D. Abnormal wound healing: keloids. Clinics in dermatology. 2007 Jan-Feb:25(1):26-32 [PubMed PMID: 17276198]
Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. Journal of cell science. 1994 May:107 ( Pt 5)():1137-57 [PubMed PMID: 7929624]
Level 3 (low-level) evidenceTanzi EL,Alster TS, Laser treatment of scars. Skin therapy letter. 2004 Jan; [PubMed PMID: 14716440]
Level 3 (low-level) evidenceFabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatology research and practice. 2010:2010():893080. doi: 10.1155/2010/893080. Epub 2010 Oct 14 [PubMed PMID: 20981308]
Niwa AB, Mello AP, Torezan LA, Osório N. Fractional photothermolysis for the treatment of hypertrophic scars: clinical experience of eight cases. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2009 May:35(5):773-7; discussion 777-8. doi: 10.1111/j.1524-4725.2009.01127.x. Epub 2008 Mar 23 [PubMed PMID: 19389105]
Level 3 (low-level) evidenceNouri K, Rivas MP, Stevens M, Ballard CJ, Singer L, Ma F, Vejjabhinanta V, Elsaie ML, Elgart GW. Comparison of the effectiveness of the pulsed dye laser 585 nm versus 595 nm in the treatment of new surgical scars. Lasers in medical science. 2009 Sep:24(5):801-10. doi: 10.1007/s10103-009-0698-8. Epub 2009 Jul 2 [PubMed PMID: 19572180]
Level 1 (high-level) evidenceKeaney TC, Tanzi E, Alster T. Comparison of 532 nm Potassium Titanyl Phosphate Laser and 595 nm Pulsed Dye Laser in the Treatment of Erythematous Surgical Scars: A Randomized, Controlled, Open-Label Study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2016 Jan:42(1):70-6. doi: 10.1097/DSS.0000000000000582. Epub [PubMed PMID: 26673432]
Level 1 (high-level) evidenceTierney E, Mahmoud BH, Srivastava D, Ozog D, Kouba DJ. Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2009 Aug:35(8):1172-80. doi: 10.1111/j.1524-4725.2009.01085.x. Epub 2009 Feb 23 [PubMed PMID: 19250300]
Level 1 (high-level) evidenceTierney EP, Eisen RF, Hanke CW. Fractionated CO2 laser skin rejuvenation. Dermatologic therapy. 2011 Jan-Feb:24(1):41-53. doi: 10.1111/j.1529-8019.2010.01377.x. Epub [PubMed PMID: 21276157]
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. Journal of the American Academy of Dermatology. 2008 May:58(5):719-37; quiz 738-40. doi: 10.1016/j.jaad.2008.01.003. Epub [PubMed PMID: 18423256]
You HJ, Kim DW, Yoon ES, Park SH. Comparison of four different lasers for acne scars: Resurfacing and fractional lasers. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2016 Apr:69(4):e87-95. doi: 10.1016/j.bjps.2015.12.012. Epub 2016 Jan 7 [PubMed PMID: 26880620]
Alexiades M. Laser and light-based treatments of acne and acne scarring. Clinics in dermatology. 2017 Mar-Apr:35(2):183-189. doi: 10.1016/j.clindermatol.2016.10.012. Epub 2016 Oct 27 [PubMed PMID: 28274357]
Keen A, Sheikh G, Hassan I, Jabeen Y, Rather S, Mubashir S, Latif I, Zeerak S, Ahmad M, Hassan A, Ashraf P, Younis F, Saqib N. Treatment of post-burn and post-traumatic atrophic scars with fractional CO(2) laser: experience at a tertiary care centre. Lasers in medical science. 2018 Jul:33(5):1039-1046. doi: 10.1007/s10103-018-2469-x. Epub 2018 Feb 23 [PubMed PMID: 29473114]
Level 2 (mid-level) evidenceTidwell WJ, Owen CE, Kulp-Shorten C, Maity A, McCall M, Brown TS. Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial. Lasers in surgery and medicine. 2016 Nov:48(9):837-843. doi: 10.1002/lsm.22562. Epub 2016 Jul 18 [PubMed PMID: 27426441]
Level 1 (high-level) evidenceGraber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2008 Mar:34(3):301-5; discussion 305-7. doi: 10.1111/j.1524-4725.2007.34062.x. Epub 2008 Jan 8 [PubMed PMID: 18190541]
Level 2 (mid-level) evidenceLee SJ, Kang JM, Chung WS, Kim YK, Kim HS. Ablative non-fractional lasers for atrophic facial acne scars: a new modality of erbium:YAG laser resurfacing in Asians. Lasers in medical science. 2014 Mar:29(2):615-9. doi: 10.1007/s10103-013-1372-8. Epub 2013 Jun 21 [PubMed PMID: 23793338]
Level 2 (mid-level) evidence